GPCR
NASDAQStockStructure Therapeutics Inc.
$55.10-3.17 (-5.45%)
52-Week Range
$14.15
$93.79
Key Stats
Market Cap
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-1.90
Volume
322.6K
Avg Volume
790.9K
Performance
1M
-25.91%
3M
-13.21%
6M
+188.12%
YTD
-14.56%
1Y
+171.71%
3Y
+151.30%
5Y
+123.85%
Price Chart
ETF Exposure
GPCR is held by 17 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| LRNZ | TRUESHARES TECHNOLOGY, AI & DEEP LEARNING ETF | 3.31% |
| OZEM | Roundhill Investments - GLP-1 & Weight Loss ETF | 2.67% |
| WDNA | WisdomTree BioRevolution Fund | 2.56% |
| SBIO | ALPS Medical Breakthroughs ETF | 2.27% |
| FDG | American Century Focused Dynamic Growth ETF | 1.03% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.64% |
| FMED | FIDELITY DISRUPTIVE MEDICINE ETF | 0.62% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 0.51% |
| MMSC | First Trust Multi-Manager Small Cap Opportunities ETF | 0.32% |
| EWX | State Street SPDR S&P Emerging Markets Small Cap ETF | 0.32% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.29% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 0.29% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.29% |
| IBB | iShares Biotechnology ETF | 0.27% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.20% |
| GXC | State Street SPDR S&P China ETF | 0.08% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
About GPCR ETF Exposure
Structure Therapeutics Inc. (GPCR) is held by 17 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $55.10. Investors can gain exposure to GPCR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold GPCR, sorted by portfolio weight.